Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Caring for Our Uninsured Patients

October 31st 2011

Ideally, all patients should receive the same oncology care, regardless of their ability to pay. The reality is often different, as this fellow can attest.

How to Perform the Perfect Bone Marrow Biopsy

October 31st 2011

Obtaining a high-quality bone marrow aspirate and biopsy is very important for the patientâ€”and for you. Following these general guidelines will help you do this successfully.

Public Speaking Tips for Fellows

October 31st 2011

All fellows will at some point in their careers be required to speak in public. This article provides a number of tips to make that task easier.

Progress Made, but More Work Lies Ahead in CLL and CRC Treatment

October 31st 2011

A look at the benefits of the chemoimmunotherapy rituximab for CLL and a look at the treatments and advances made in treating metastatic CRC.

Dr. Mistry on Gaucher Disease Entering a New Era

October 27th 2011

Dr. Pramod Mistry from Yale University School of Medicine on Gaucher Disease Entering a New Era

Dr. Grabowski Explains the Effects of Enzyme Therapy

October 24th 2011

Dr. Gregory A. Grabowski from Cincinnati Children's Hospital Medical Center Explains the Effects of Enzyme Therapy

Dr. Vivaldi on the Gaucher Disease Transformation

October 24th 2011

Dr. Rogerio Vivaldi the President of Genzyme Corporation on the Transformation of Gaucher Disease

Dr. Mistry Explains the History of Gaucher Disease

October 21st 2011

Dr. Pramod Mistry from the Yale University School of Medicine Explains the History of Gaucher Disease

Dr. Moscicki on His Experience With Lysosomal Diseases

October 21st 2011

Dr. Richard Moscicki from Chief Medical Officer, Genzyme Corporation, on His Experience With Lysosomal Diseases

October 2011: Trials in Progress

October 21st 2011

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Meeting.

Dr. Goy Highlights Recent Advances in Oncology

October 14th 2011

Dr. Andre Goy from John Theurer Cancer Center Highlights Recent Advances in Oncology

Case Presentation: Myelodysplastic Syndromes

October 13th 2011

Myelodysplastic syndromes (MDS) are a group of hematological conditions affecting the blood stem cells in the bone marrow.

Dr. Goy on Novel Therapies at the JTCC Conference

October 11th 2011

Dr. Andre Goy from John Theurer Cancer Center on Integrating Novel Therapies Into the JTCC Conference

Dr. Goy on the Upcoming Conference at the JTCC

October 10th 2011

Dr. Andre Goy from John Theurer Cancer Center on the Upcoming Conference at John Theurer Cancer Center

Living With Multiple Myeloma: Nurses as the Lifeline

October 7th 2011

In 2001, Doug Rickert, a 46-year-old industrial management consultant and married father of 3, heard the life-altering words, "softball-sized tumor pressing against your spinal canal."

Pharmaceutical Company Profile: Celgene Corporation

September 30th 2011

Through the success of Revlimid and other drugs, Celgene has become a respected and powerful player in the biopharmaceutical industry in recent years.

Brentuximab Vedotin Proves Effective Against Lymphomas

September 27th 2011

Brentuximab vedotin showed very positive results in lymphoma patients in several early trials, prompting the FDA's Oncologic Drugs Advisory Committee to unanimously recommend accelerated approval for the drug.

Back on the Horse: Ron Rogers

August 24th 2011

You'd never know that Rogers has had multiple myeloma for almost 11 years -- and that's just the way he likes it.

ASCO Highlights: Trials in Progress

August 23rd 2011

The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.

Updates on Multiple Myeloma Diagnosis and Treatment Strategies

August 23rd 2011

Progress in our understanding of multiple myeloma pathogenesis has led to the identification of new therapeutic targets.